Floatz logo

Romidepsin

Adenosine Deaminase Deficiency

Great Ormond Street Hospital for Children NHS Foundation TrustSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Adenosine Deaminase Deficiency cohort.

Asset / SponsorPhaseRating
Infusion Of Autologous Efs-Ada Lv Cd34+ Cells
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1/2CCC
Busulphan
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1/2CCC
Fludarabine
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1/2CCC
Peg-Ada
Great Ormond Street Hospital for Children NHS Foundation Trust
Phase 1/2CCC
Monomethyl Fumarate
Fred Hutchinson Cancer Center
Phase 1CC
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 1CC
SIMOLADAGENE AUTOTEMCEL LENTIVIRAL VECTOR
University of California, Los Angeles
D

Same molecule, other indications

Romidepsin is also rated in:

Myelodysplastic/Myeloproliferative DiseasesDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Mycosis Fungoides/Sezary SyndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Multiple Myeloma and Plasma Cell NeoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →